Broad-spectrum targeted next-generation sequencing: is it ready for routine deployment in intensive care units for severe pneumonia? - Summary - MDSpire

Broad-spectrum targeted next-generation sequencing: is it ready for routine deployment in intensive care units for severe pneumonia?

  • By

  • How-Yang Tseng

  • Yu-Chang Fu

  • Yue-Hua Su

  • Yu-Chu Kuo

  • Shinn-Jye Liang

  • Yi-Cheng Shen

  • Wei-Cheng Chen

  • Chieh-Lung Chen

  • Yu-Chao Lin

  • Meng-Yu Cheng

  • Chih-Hao Chen

  • Chih-Yen Tu

  • Zi-Lun Lai

  • Po-Ren Hsueh

  • April 2, 2026

  • 0 min

Share

Objective:

To evaluate the comparative diagnostic performance of targeted next-generation sequencing (tNGS) relative to standard microbiological tests in ICU patients with severe pneumonia, highlighting its potential impact on patient care and addressing challenges for its routine implementation.

Key Findings:
  • Overall analytical detection rates were 90.2% for RPIP and 82.4% for standard testing, indicating a significant diagnostic advantage.
  • Adjudicated causative pathogen identification was similar between RPIP (47.1%) and standard testing (49.0%), suggesting comparable efficacy.
  • RPIP provided additional clinically actionable yield in 23.5% of patients, highlighting its potential to enhance clinical decision-making.
  • 45.1% of cases remained without an adjudicated causative pathogen after clinical review, indicating a need for further diagnostic strategies.
Interpretation:

While tNGS shows promise in detecting a broader range of pathogens, its clinical utility may be limited compared to standard tests in many cases, necessitating further research to clarify its optimal use and cost-effectiveness.

Limitations:
  • Unclear optimal timing for performing NGS in ICU patients, which may affect diagnostic yield.
  • Limited use of AMR information generated by tNGS to guide therapy, indicating a gap in clinical application.
  • High proportion of cases without identified pathogens suggests potential non-infectious conditions, warranting further investigation.
  • Laboratory workflow challenges and long turnaround times hinder routine implementation, necessitating process optimization.
Conclusion:

tNGS has potential benefits in diagnosing severe pneumonia but faces significant challenges that need to be addressed before it can be routinely implemented in ICU settings, emphasizing the importance of overcoming these barriers.

Original Source(s)

Related Content